Trial Profile
Investigation on Safety, Tolerability and Bioavailability of Oral Semaglutide in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jan 2019
Price :
$35
*
At a glance
- Drugs Semaglutide (Primary) ; Semaglutide (Primary) ; Semaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; First in man
- Sponsors Novo Nordisk
- 18 Dec 2018 Results assessing safety of Semaglutide in healthy subjects, published in the Clinical Pharmacokinetics.
- 15 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 May 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.